DYADIC INTERNATIONAL INC Earnings Per Share (Basic)
DYADIC INTERNATIONAL INC (DYAI) reported Earnings Per Share (Basic) of -$0.06 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-12
- DYADIC INTERNATIONAL INC earnings per share, basic for the quarter ending 2026-06-30 was -$0.06.
- DYADIC INTERNATIONAL INC earnings per share, basic for the quarter ending 2026-03-31 was -$0.05.
- DYADIC INTERNATIONAL INC earnings per share, basic for the quarter ending 2025-09-30 was -$0.06.
- DYADIC INTERNATIONAL INC earnings per share, basic for the quarter ending 2025-06-30 was -$0.06.
- DYADIC INTERNATIONAL INC earnings per share, basic for fiscal 2025 was -$0.23.
- DYADIC INTERNATIONAL INC earnings per share, basic for fiscal 2024 was -$0.20.
- DYADIC INTERNATIONAL INC earnings per share, basic for fiscal 2023 was -$0.24.
- DYADIC INTERNATIONAL INC earnings per share, basic for fiscal 2022 was -$0.34.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.06 10-Q · filed 2026-08-12 | -$0.11 10-Q · filed 2026-08-12 | ||
| 2026-03-31 | -$0.05 10-Q · filed 2026-05-13 | |||
| 2025-12-31 | -$0.23 10-K · filed 2026-03-25 | |||
| 2025-09-30 | -$0.06 10-Q · filed 2025-11-12 | -$0.17 10-Q · filed 2025-11-12 | ||
| 2025-06-30 | -$0.06 10-Q · filed 2026-08-12 | -$0.13 10-Q · filed 2026-08-12 | ||
| 2025-03-31 | -$0.07 10-Q · filed 2026-05-13 | |||
| 2024-12-31 | -$0.20 10-K · filed 2026-03-25 | |||
| 2024-09-30 | -$0.01 10-Q · filed 2025-11-12 | -$0.15 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | -$0.07 10-Q · filed 2025-08-13 | -$0.14 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | -$0.07 10-Q · filed 2025-05-14 | -$0.14 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$0.20 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$0.27 derived: net income ÷ weighted average shares · filed 2026-05-12 |
| 2023-12-31 | -$0.07 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$0.13 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$0.20 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$0.24 10-K · filed 2025-03-26 |
| 2023-09-30 | -$0.06 10-Q · filed 2024-11-12 | -$0.13 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$0.16 10-Q · filed 2024-11-12 | -$0.24 derived: net income ÷ weighted average shares · filed 2024-11-12 |
| 2023-06-30 | -$0.07 10-Q · filed 2024-08-13 | -$0.11 10-Q · filed 2024-08-13 | -$0.18 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$0.25 derived: net income ÷ weighted average shares · filed 2024-11-12 |
| 2023-03-31 | -$0.03 10-Q · filed 2024-05-14 | -$0.11 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$0.17 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$0.29 derived: net income ÷ weighted average shares · filed 2024-11-12 |
| 2022-12-31 | -$0.08 derived: net income ÷ weighted average shares · filed 2024-03-28 | -$0.14 derived: net income ÷ weighted average shares · filed 2024-03-28 | -$0.26 derived: net income ÷ weighted average shares · filed 2024-03-28 | -$0.34 10-K · filed 2024-03-28 |
| 2022-09-30 | -$0.06 10-Q · filed 2023-11-08 | -$0.18 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$0.27 10-Q · filed 2023-11-08 | |
| 2022-06-30 | -$0.12 10-Q · filed 2023-08-09 | -$0.20 10-Q · filed 2023-08-09 | ||
| 2022-03-31 | -$0.09 10-Q · filed 2023-05-10 | |||
| 2021-12-31 | -$0.47 10-K · filed 2023-03-29 | |||
| 2021-09-30 | -$0.06 10-Q · filed 2022-11-10 | -$0.32 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | -$0.14 10-Q · filed 2022-08-10 | -$0.26 10-Q · filed 2022-08-10 | ||
| 2021-03-31 | -$0.12 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |